In other aneurysm-related diseases, Toghill et al.’s study (Toghill et al., 2018) found that SMYD2 gene promoter methylation may be involved in the pathobiological development of abdominal aortic aneurysm by reducing SMYD2 gene expression. This evidence concerns the gene SMYD2 and abdominal aortic aneurysm.